Augmented reality visor to dramatically improve surgery

Augmented reality visor to dramatically improve surgery

VOSTARS medical visor is a head-mounted display system capable of superimposing patient’s X-ray images in 3D unison with their anatomy.

March 8, 2017

Employing new photonics technology, European scientists are developing a new augmented reality surgical visor in a bid to improve accuracy of interventions, showing anesthetic and medical data while superimposing a patient’s X-ray in perfect unison with their body, meaning surgeons never having to look away during an operation and surgery times reduced by more than 20 minutes for every 3 hours.

The VOSTARS (Video Optical See-Through Augmented Reality surgical System) medical visor is a head-mounted display (HMD) system that is capable of superimposing the patient’s X-ray images in perfect 3D unison with their anatomy.

The visor also presents a patient’s anaesthetic data, heart rate, body temperature, blood pressure, and breathing rates, conveniently into the surgeon’s field of vision, in a drive to increase accuracy by focusing on the operation and reduce time by never having to look away.

The project forecasts a significant improvement of the intervention accuracy coupled with a reduction in times spent in an operation and under anesthesia by at least 11%.

Although augmented reality for surgical procedures has been talked about in academic and industrial research since the 1990s, a tool joining a surgeon’s natural perception with patient data has not yet been widely implemented.

However, it has been the use of photonics components, with the small, high-luminous micro display, the LED optical waveguide, and the array of microns to project a 2D X-ray image in front of the user that has been fundamental to realizing this one-time science fiction.

Project coordinator Dr. Vincenzo Ferrari, biomedical engineering researcher at the Department of Information Engineering, at the University of Pisa, explains that, “With this state-of-the-art, highly ergonomic visor, we intend to provide all the information required to improve surgery. The primary goal is to reduce not just surgery times, but also the time spent under anesthesia and the cost involved in any operation.”

“For the patient, this means saving off 20 minutes of every 3 hours of surgery and the guarantee of an extremely accurate intervention,” Ferrari says.

In the same way that a facing camera on a smartphone films moving images, the VOSTARS system works by capturing what the surgeon sees from a head-mounted camera. The system then merges this footage of reality with the patient’s medical images, from CT, MRI, or 3DUS scans.

The central processor, using the most advanced registration techniques available for surgical navigation, then presents a real-time hybrid image on the visor dashboard to the surgeon.

Imagine driving with a sat-nav: we know how to drive and roughly where to go, but with real-time information, like speed, distance and time presented to us, we can take the most efficient route in the quickest time and perhaps more safely. However, rather than having that information on a small GPS screen, our important patient data, like the surgical target in the anatomy, anesthestic info, breathing and heart rates for example, are all integrated instantly into the surgical visor. A clinician can move freely while still seeing the patient, the hybrid X-ray image and all of critical data all at once in a surgical dashboard inside the screen. The surgeon, the patient and the procedure are all at one.

Hybrid version
Scientists at VOSTARS are building a hybrid of the two existing AR headsets approaches that combines all the benefits of both a video see-through (VST) system and optical see-through (OST) head-mounted display.

Fabrizio Cutolo, engineer and expert in wearable augmented reality systems, believes neither VST nor OST alone was suitable for operating on a live patient, saying, “When operating on a real person, it was clear to us that the benefits of OST and VST systems could be combined to make a hybrid device.”

In OST systems, as in Microsoft Hololens, the user has a direct view of the natural environment with the computer-generated images superimposed on a user’s field of vision using a semi-transparent mirror. This gives the user a more naturalistic experience, superimposing small amounts of the virtual onto the real world.

With VST systems (as seen in the Occulus Rift headsets), the user is submerged in the virtual world, seeing through a closed HMD together with stereo cameras, experiencing life through screens. Since VST systems capture the video-image as seen by the user in real time it is good for aligning the real and virtual worlds.

“For something as critical as an operation, we had to have the naturalistic feel of OST, while having the fluid interaction of the VST. Therefore a brand new device had to be made from scratch, rather than extend an existing technology. The VST-OST Augmented Reality hybrid was born,” Cutolo says.

Already 3 months into the 3 year project, VOSTARS aims to have a working prototype of the hybrid device ready in May 2018. Initially being tested on a number of procedures to the head, including maxillofacial, neurology, ear, nose and throat, and orthopedic, the project hopes to be available to end users in 3 years, with mass production by 2022.

Coordinated in Italy at Department of Information Engineering and the EndoCAS Center for Computer Assisted Surgery (Pisa University), the VOSTARS project received a grant of €3,816,440 from Horizon 2020 via the Photonics Public Private Partnership.

Participants from four European countries include: (Germany) SCOPIS GMBH, Charité – Universitätsmedizin Berlin, Sankt Gertrauden Krankenhaus GMBH, Technische Universitaet Muenchen, Pilotfish GMBH; (Italy) Alma Mater Studiorum-Universita Di Bologna, Scuola Superiore Di Studi Universitare E Di Perfezionamento Sant'Anna; (United Kingdom)VREO Innovation; (France) Optinvent, Commissariat A L’Energie Atomique et aux Energies Alternatives.

About Photonics21
Photonics21 is the European Technology Platform (ETP) for photonics, a technology encompassing all of the products and processes around the emission, manipulation and detection of light. Photonics is integral to a wide range of industries that include the medical, healthcare, transport, manufacturing, and telecommunications sectors.

"Photonics21" was set up in December 2005 to bring the community of photonics researchers and industries together. The European Commission defined photonics as one of five European Key Enabling Technologies (KET's) in September 2009. Shortly after, the European Research & Innovation Program Horizon 2020 invited Photonics21 to become a Public Private Partnership (PPP). The Photonics 21 Association, a legal entity under Belgium law, became the private contract partner in November 2013 in a PPP in conjunction with the EU Commission.

Today Photonics21 represents more than 3000 personal members from across Europe and abroad. Our members are experts in the photonics industry, research organizations and universities who actively engage with us to develop a joint photonics strategy for future research and innovation in Europe.

With the global photonics market growing from €350 Billion in 2011 to €447 Billion in 2015, Photonics remains a strong industry. The European photonics industry, estimated to be worth €70 billion, has considerable global leadership positions and employs over 300,000 people directly.

With positive growth forecast, current industry trends like digitalization, resource efficiency, individual and zero failure production will drive the photonics industry further.